DTaP-hepatitis B (recombinant)-inactivated poliovirus vaccine (GlaxoSmithKline)

N/A

Report date: 2025/02/09 20:00:08

Base Information

Drug NameDTaP-hepatitis B (recombinant)-inactivated poliovirus vaccine (GlaxoSmithKline)
Drug Alias NameInfanrix PeNta็™ฝๅ–‰ใ€็ ดไผค้ฃŽ็ฑปๆฏ’็ด ๅ’Œๆ— ็ป†่ƒž็™พๆ—ฅๅ’ณๅธ้™„ใ€ไน™ๅž‹่‚็‚Ž๏ผˆ้‡็ป„๏ผ‰ๅ’Œ็ญๆดป็š„่„Š้ซ“็ฐ่ดจ็‚Ž็—…ๆฏ’่”ๅˆ็–ซ่‹— - ่‘›ๅ…ฐ็ด ๅฒๅ…‹Infanrix-HepB-IPVInfanrixDTPa-HepB-IPVPediarix
ClassificationVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Biological material > Toxoid vaccineVaccines > Biological material > Viral vaccine +[5]ย 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis BPoliomyelitisTetanus +[7]ย 
Global Approved IndicationsHepatitis BPoliomyelitisTetanus +[5]ย 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2002/12/13
Country/TerritoryBelgiumUnited StatesMexico +[6]ย 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Biologicals SA
Inactive CompaniesGlaxosmithkline PlcNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsHepatitis BPoliomyelitisTetanus +[5]ย 
Inactive IndicationsHaemophilus InfectionsMeningococcal Infections

Other Information

ATC CodeJ07CA12
Related LinksN/A